In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...